PMC:7696151 / 13196-13426 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"407","span":{"begin":203,"end":211},"obj":"Species"},{"id":"421","span":{"begin":27,"end":30},"obj":"Chemical"},{"id":"422","span":{"begin":73,"end":84},"obj":"Chemical"},{"id":"423","span":{"begin":104,"end":114},"obj":"Chemical"},{"id":"438","span":{"begin":188,"end":202},"obj":"Disease"}],"attributes":[{"id":"A407","pred":"tao:has_database_id","subj":"407","obj":"Tax:9606"},{"id":"A421","pred":"tao:has_database_id","subj":"421","obj":"MESH:D006886"},{"id":"A422","pred":"tao:has_database_id","subj":"422","obj":"MESH:D006918"},{"id":"A423","pred":"tao:has_database_id","subj":"423","obj":"MESH:D016049"},{"id":"A438","pred":"tao:has_database_id","subj":"438","obj":"MESH:D015658"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"this regard, 400 mg/day of HCQ in a combination regimen with 1000 mg/day hydroxyurea and 250–400 mg/day didanosine (dosed per body weight) was administered for 48 weeks to 22 asymptomatic HIV-1 infected patients naïve to antiretro"}